425: Clearwater Analytics to Acquire Enfusion in Transformative Deal, Creating Front-to-Back Investment Management Platform

Clearwater Analytics plans to acquire Enfusion for approximately $760 million in cash and stock, aiming to create a comprehensive front-to-back platform for the investment management industry.

Summary

• Clearwater Analytics announced its planned acquisition of Enfusion, a cloud-native SaaS platform for asset managers and hedge funds.
• The acquisition aims to create a front-to-back platform for the investment management industry, leveraging the strengths of both companies.
• Clearwater will pay $11.25 per share for Enfusion, consisting of $5.85 in cash and $5.40 in Clearwater Class A Common Stock, representing a 13% premium over Enfusion's January 10, 2025 closing price.
• The deal includes $760 million in cash and the issuance of 23 to 28 million Clearwater shares, representing 10% to 12% of Clearwater's fully diluted share count.
• Clearwater has secured $800 million in term loan and a $200 million revolving line of credit to finance the cash portion of the acquisition.
• The combined company is projected to have approximately $750 million in revenues in 2025.
• Clearwater expects to reaccelerate Enfusion's growth to 20% over the next two years and improve Enfusion's EBITDA margins by 800 basis points over two years.
• The acquisition is expected to be midto high-single digit percentage accretive to Clearwater's non-GAAP EPS in 2026.
• Enfusion's management expects revenue for full year 2024 to be approximately $201 million to $202 million, representing 15% to 16% year-over-year growth.
• Enfusion's management expects end-of-year ARR to be approximately $210 million to $211 million, representing 13% to 14% year-on-year growth.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the strategic rationale behind the acquisition, the expected synergies, and the projected financial benefits. While there are risks associated with integration and debt, the overall tone is optimistic about the future prospects of the combined company.

Positives

• The acquisition creates a comprehensive front-to-back platform, integrating front, middle, and back-office functionalities.
• It increases Clearwater's right to win in the asset management market by combining intellectual property and engineering talent.
• Cross-selling opportunities exist, particularly taking Enfusion's IBOR, portfolio management, and order management functionality to Clearwater clients.
• The acquisition expands Clearwater's presence in the hedge fund industry, where Enfusion has a strong track record.
• It increases Clearwater's overall total addressable market (TAM) by approximately $1.9 billion.
• The combination enhances Clearwater's international presence, leveraging Enfusion's existing global footprint.
• Significant synergy opportunities exist, including accelerated growth, improved unit economics, and G&A efficiencies.
• The acquisition is expected to be accretive to Clearwater's non-GAAP EPS in 2026.
• Enfusion's single instance, multi-tenant, cloud-native platform aligns with Clearwater's technology strategy.

Negatives

• Clearwater will take on approximately $800 million in term loan debt and a $200 million revolving line of credit, resulting in a combined gross leverage of approximately 3.7 times at close.
• The integration of Enfusion's operations and technology with Clearwater's may present challenges.
• There is a risk that cost savings, synergies, and growth from the acquisition may not be fully realized or may take longer to realize than expected.
• Clearwater needs to successfully retain and incentivize Enfusion's employees following the close of the acquisition.
• Clearwater needs to successfully retain Enfusion's clients.

Risks

• The ability to successfully close the acquisition is subject to customary closing conditions.
• Clearwater's ability to successfully integrate the operations and technology of Enfusion is not guaranteed.
• Retaining and incentivizing Enfusion's employees after the acquisition is crucial for success.
• Retaining Enfusion's clients is essential to realize the expected benefits of the acquisition.
• Repaying the debt incurred for the acquisition and meeting financial covenants could pose challenges.
• Cost savings, synergies, and growth from the acquisition may not be fully realized or may take longer than expected.
• The risk factors outlined in Clearwater's and Enfusion's SEC filings could impact the success of the acquisition.

Future Outlook

Clearwater expects to reaccelerate growth at Enfusion over the next two years, reaching a 20% growth rate. The company also anticipates improving Enfusion's EBITDA margins by 400 basis points in the first year after close and an additional 400 basis points in the second year.

Management Comments

• Sandeep Sahai: 'We are very happy to announce Clearwaters planned acquisition of Enfusion...'
• Sandeep Sahai: 'This combination accelerates our journey towards building a front-to-back platform for the investment management industry...'
• Jim Cox: 'We are incredibly excited about this combination and believe that together we will build a modern cloud-native, front-to-back platform capable of addressing the increasingly complex and global needs of our clients.'

Industry Context

This acquisition reflects a trend in the investment management industry towards integrated, front-to-back platforms that streamline operations and improve data management. Clearwater's move to acquire Enfusion positions it to compete more effectively with larger, more diversified financial technology providers.

Comparison to Industry Standards

• Clearwater's acquisition of Enfusion aims to create a platform comparable to offerings from companies like BlackRock (Aladdin) and SimCorp, which provide integrated solutions for investment management.
• The focus on a single instance, multi-tenant, cloud-native architecture aligns with industry best practices for scalability and efficiency.
• The targeted EBITDA margin improvements of 800 basis points over two years demonstrate a commitment to operational excellence, comparable to industry leaders.
• The projected combined revenue of $750 million in 2025 positions Clearwater as a significant player in the investment management technology market.

Stakeholder Impact

• Shareholders of both Clearwater and Enfusion are expected to benefit from the synergies and growth opportunities created by the acquisition.
• Employees of both companies may experience changes as a result of the integration, but the combined company is expected to offer new opportunities.
• Clients of both companies are expected to benefit from the comprehensive front-to-back platform and enhanced service offerings.
• The acquisition could impact competitors in the investment management technology market.

Next Steps

• Clearwater will file a Registration Statement on Form S-4 with the SEC.
• Enfusion will file a proxy statement/prospectus with the SEC.
• Enfusion's security holders will vote on the transaction.
• The transaction is subject to customary closing conditions.
• Clearwater will integrate Enfusion's operations and technology.
• Clearwater will focus on reaccelerating Enfusion's growth and improving its profitability.

Key Dates